Cancer Prevention News and Research

RSS

Study finds declines in smoking cessation activity after the onset of COVID-19

A new study led by researchers at the American Cancer Society (ACS), shows serious smoking cessation activity declined among adults in the United States immediately after the onset of COVID-19 and persisted for over a year.

1 Aug 2022

Celebrating the role of aspirin as chemopreventative agent against cancer

A special edition issue of the Aspirin Summaries has been published '125 years of aspirin - the role of aspirin in cancer' issue 2022.

29 Jul 2022

New guidelines for breast cancer screening and diagnosis helps people understand their personal risk

The National Comprehensive Cancer Network has published new NCCN Guidelines for Patients: Breast Cancer Screening and Diagnosis to help people understand their personal risk for breast cancer,

27 Jul 2022

NHS Breast Screening Programme confers only a low risk of overdiagnosis

In the UK, breast cancer accounts for 31% of all new cancers diagnosed in women each year, with cases having increased by 4% in the last decade.

20 Jul 2022

Rice researchers use deactivated Cas9 proteins to synthetically trigger the transcription of genes

Rice University researchers have demonstrated that CRISPR-Cas9, increasingly famous as a gene-editing tool, can be employed in powerful additional ways in human cells.

18 Jul 2022

Addition of brentuximab vedotin to chemotherapy has a positive impact for patients with Hodgkin lymphoma

A study led by researchers from Mayo Clinic Comprehensive Cancer Center has found that the addition of brentuximab vedotin to standard chemotherapy treatment improves overall survival in patients with Hodgkin Lymphoma, when compared to the current standard of chemotherapy alone.

14 Jul 2022

Experts propose a roadmap for the development of human-free sunscreen testing

Exposing humans to ultraviolet radiation to test sunscreen effectiveness should be phased out, according to scientists and cancer experts.

14 Jul 2022

SARS-Arena reveals conserved parts of viral proteins that cause COVID-19

Vaccines may need to dig a little deeper to stop SARS-CoV-2. Rice University researchers are providing a new shovel.

14 Jul 2022

Constant activation of p53 in hepatocytes of CLD patients could promote the development of liver cancer

p53 is one of the most important proteins in cancer biology. Often referred to as a "guardian of the genome," p53 becomes activated in response to various cellular stressors like DNA damage.

12 Jul 2022

UT Southwestern researchers reveal the physical mechanism behind a neurological autoimmune disease

Using UT Southwestern's Cryo-Electron Microscopy Facility, researchers for the first time have captured images of an autoantibody bound to a nerve cell surface receptor, revealing the physical mechanism behind a neurological autoimmune disease.

11 Jul 2022

Newly identified gut bacterial strains could pave the way for IBD and colon cancer prevention

Researchers have isolated five strains of gut bacteria that could pave the way for new inflammatory bowel disease treatments and potentially help prevent some forms of bowel cancer.

5 Jul 2022

Study finds above-average rates of mortality from gastric cancer in South Florida

South Florida counties have above-average rates of mortality from gastric cancer, according to a new study published in the journal Gastroenterology by investigators at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine.

29 Jun 2022

Biodegradable nanomaterials can take images and deliver medicine to combat peripheral arterial disease

A University of Texas at Arlington bioengineer is leading a project that will develop biodegradable nanomaterials that will take pictures and deliver medicine to combat peripheral arterial disease (PAD).

24 Jun 2022

Study finds a more effective treatment option for HER2 mutant metastatic breast cancer

Breast cancers with HER2 mutations respond to the drug neratinib, but the responses are variable and often not durable.

23 Jun 2022

New report estimates cancer prevalence in the U.S. and provides survivorship statistics

A new report led by researchers at the American Cancer Society in collaboration with the National Cancer Institute shows more than 18 million Americans (8.3 million males and 9.7 million females) with a history of cancer were living in the United States as of January 1, 2022, with a little over 12 million (67%) aged 65 years or older.

23 Jun 2022

KHN’s ‘What the Health?’: The FDA goes after nicotine

The FDA this week launched a crackdown on smoking and vaping — ordering the vaping device Juul to be taken off the market and announcing its intention to require makers of cigarettes and other tobacco products to reduce the amount of nicotine in them.

23 Jun 2022

Simple blood test can predict liver cancer risk in NAFLD patients

An estimated one-quarter of adults in the U.S. have nonalcoholic fatty liver disease (NAFLD), an excess of fat in liver cells that can cause chronic inflammation and liver damage, increasing the risk of liver cancer.

22 Jun 2022

New perspective shows high burden of breast cancer mortality for Black women began in the 1980's

A new perspective by researchers from the American Cancer Society and the University of Texas Health Science Center at San Antonio shows the high burden of breast cancer mortality in African American (Black) women versus White women began in the United States in the 1980's.

18 Jun 2022

International researchers will receive $25 million award to investigate the early stages of cancer development

A world-class team of researchers co-led by UC San Francisco's Allan Balmain, PhD, FRS, has been selected to receive a $25 million Cancer Grand Challenges award to investigate the very early stages of cancer development.

16 Jun 2022

Androgen receptor signaling affects response to targeted therapy in people with melanoma

Androgen receptor (AR) signaling affects response to BRAF/MEK inhibitor therapy in both males and females with melanoma, researchers from The University of Texas MD Anderson Cancer Center showed in a study published today in Nature.

15 Jun 2022

Cancer Prevention News and Research

Study finds declines in smoking cessation activity after the onset of COVID-19

Celebrating the role of aspirin as chemopreventative agent against cancer

New guidelines for breast cancer screening and diagnosis helps people understand their personal risk

NHS Breast Screening Programme confers only a low risk of overdiagnosis

Rice researchers use deactivated Cas9 proteins to synthetically trigger the transcription of genes

Addition of brentuximab vedotin to chemotherapy has a positive impact for patients with Hodgkin lymphoma

Experts propose a roadmap for the development of human-free sunscreen testing

SARS-Arena reveals conserved parts of viral proteins that cause COVID-19

Constant activation of p53 in hepatocytes of CLD patients could promote the development of liver cancer

UT Southwestern researchers reveal the physical mechanism behind a neurological autoimmune disease

Newly identified gut bacterial strains could pave the way for IBD and colon cancer prevention

Study finds above-average rates of mortality from gastric cancer in South Florida

Biodegradable nanomaterials can take images and deliver medicine to combat peripheral arterial disease

Study finds a more effective treatment option for HER2 mutant metastatic breast cancer

New report estimates cancer prevalence in the U.S. and provides survivorship statistics

KHN’s ‘What the Health?’: The FDA goes after nicotine

Simple blood test can predict liver cancer risk in NAFLD patients

New perspective shows high burden of breast cancer mortality for Black women began in the 1980's

International researchers will receive $25 million award to investigate the early stages of cancer development

Androgen receptor signaling affects response to targeted therapy in people with melanoma

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News